Accelerate PhenoTestTM BC Kit Versus Conventional Methods for Identification and Antimicrobial Susceptibility Testing of Gram-Positive Bloodstream Isolates: Potential Implications for Antimicrobial Stewardship

Annals of Pharmacotherapy

Volumn 52, Issue 8, 2018, Pages 754-762

  Sofjan, Amelia K ^a   Casey, Benjamin O ^a   Xu, Boxin A ^a   Amadio, Jonathan ^a   Restrepo, Alejandro ^b   Alam, M Jahangir ^a   Garey, Kevin W ^a  

^a UNIVERSITY OF HOUSTON   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

antibiotics; bacterial infections; diagnostic agents; infectious disease; infectious diseases

Indexed keywords

AMPICILLIN; CARBAPENEM DERIVATIVE; CEFAZOLIN; CEFEPIME; CEFOXITIN; CEFTRIAXONE; DAPTOMYCIN; ERYTHROMYCIN; LINEZOLID; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ANTIMICROBIAL STEWARDSHIP; ARTICLE; BACTERIUM ISOLATE; BLOOD CULTURE; BLOODSTREAM INFECTION; CANDIDA ALBICANS; CANDIDA GLABRATA; CITROBACTER; COAGULASE NEGATIVE STAPHYLOCOCCUS; COHORT ANALYSIS; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; HUMAN; INTERMETHOD COMPARISON; KLEBSIELLA; MAJOR CLINICAL STUDY; MONTE CARLO METHOD; NONHUMAN; PRIORITY JOURNAL; PROTEUS; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SERRATIA MARCESCENS; SIMULATION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS LUGDUNENSIS; BLOOD; DRUG EFFECT; GRAM POSITIVE BACTERIUM; GRAM POSITIVE INFECTION; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ADULT; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL STEWARDSHIP; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES;

EID: 85044780780     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/1060028018765486     Document Type: Article

References (34)

1. Magill SS, Edwards JR, Bamberg W. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370:1198-1208
2. Billington EO, Phang SH, Gregson DB. Incidence, risk factors, and outcomes for Enterococcus spp. blood stream infections: a population-based study. Int J Infect Dis. 2014;26:76-82
3. McDanel JS, Perencevich EN, Diekema DJ. Comparative effectiveness of beta-lactams versus vancomycin for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections among 122 hospitals. Clin Infect Dis. 2015;61:361-367
4. Stryjewski ME, Szczech LA, Benjamin DK, Jr. Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis. 2007;44:190-196
5. Zasowski EJ, Claeys KC, Lagnf AM. Time is of the essence: the impact of delayed antibiotic therapy on patient outcomes in hospital-onset enterococcal bloodstream infections. Clin Infect Dis. 2016;62:1242-1250
6. Souvenir D, Anderson DE, Jr Palpant S. Blood cultures positive for coagulase-negative staphylococci: antisepsis, pseudobacteremia, and therapy of patients. J Clin Microbiol. 1998;36:1923-1926
7. Aitken SL, Hemmige VS, Koo HL. Real-world performance of a microarray-based rapid diagnostic for Gram-positive bloodstream infections and potential utility for antimicrobial stewardship. Diagn Microbiol Infect Dis. 2015;81:4-8
8. Banerjee R, Teng CB, Cunningham SA. Randomized trial of rapid multiplex polymerase chain reaction-based blood culture identification and susceptibility testing. Clin Infect Dis. 2015;61:1071-1080
9. Huang AM, Newton D, Kunapuli A. Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. Clin Infect Dis. 2013;57:1237-1245
10. Perez KK, Olsen RJ, Musick WL. Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch Pathol Lab Med. 2013;137:1247-1254
11. Beyda ND, Alam MJ, Garey KW. Comparison of the T2Dx instrument with T2Candida assay and automated blood culture in the detection of Candida species using seeded blood samples. Diagn Microbiol Infect Dis. 2013;77:324-326
12. TM BC Kit: Instructions for Use. Tucson, AZ: Accelerate Diagnostics, Inc; 2017
13. Palmer HR, Weston J, Gentry L. Improving patient care through implementation of an antimicrobial stewardship program. Am J Health Syst Pharm. 2011;68:2170-2174
14. Barlam TF, Cosgrove SE, Abbo LM. Executive summary: implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62:1197-1202
15. Food and Drug Administration. Statistical guidance on reporting results from studies evaluating diagnostic tests. https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm071148.htm#7. Accessed February 5, 2018
16. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: 22nd Informational Supplement. M100-S22. Wayne, PA: Clinical and Laboratory Standards Institute; 2012
17. Perez KK, Olsen RJ, Musick WL. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia. J Infect. 2014;69:216-225
18. Timbrook TT, Morton JB, McConeghy KW. The effect of molecular rapid diagnostic testing on clinical outcomes in bloodstream infections: a systematic review and meta-analysis. Clin Infect Dis. 2017;64:15-23
19. Marschal M, Bachmaier J, Autenrieth I. Evaluation of the Accelerate Pheno system for fast identification and antimicrobial susceptibility testing from positive blood culture in Gram-negative bloodstream infection. J Clin Microbiol. 2017;55:2116-2126
20. Ward C, Stocker K, Begum J. Performance evaluation of the Verigene(R) (Nanosphere) and FilmArray(R) (BioFire(R)) molecular assays for identification of causative organisms in bacterial bloodstream infections. Eur J Clin Microbiol Infect Dis. 2015;34:487-496
21. Samuel LP, Tibbetts RJ, Agotesku A. Evaluation of a microarray-based assay for rapid identification of Gram-positive organisms and resistance markers in positive blood cultures. J Clin Microbiol. 2013;51:1188-1192
22. Buchan BW, Ginocchio CC, Manii R. Multiplex identification of Gram-positive bacteria and resistance determinants directly from positive blood culture broths: evaluation of an automated microarray-based nucleic acid test. PLoS Med. 2013;10:e1001478
23. Altun O, Almuhayawi M, Ullberg M. Clinical evaluation of the FilmArray blood culture identification panel in identification of bacteria and yeasts from positive blood culture bottles. J Clin Microbiol. 2013;51:4130-4136
24. Rand KH, Delano JP. Direct identification of bacteria in positive blood cultures: comparison of two rapid methods, FilmArray and mass spectrometry. Diagn Microbiol Infect Dis. 2014;79:293-297
25. Southern TR, VanSchooneveld TC, Bannister DL. Implementation and performance of the BioFire FilmArray(R) Blood Culture Identification panel with antimicrobial treatment recommendations for bloodstream infections at a midwestern academic tertiary hospital. Diagn Microbiol Infect Dis. 2015;81:96-101
26. Bauer KA, West JE, Balada-Llasat JM. An antimicrobial stewardship program’s impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. Clin Infect Dis. 2010;51:1074-1080
27. Parta M, Goebel M, Thomas J. Impact of an assay that enables rapid determination of Staphylococcus species and their drug susceptibility on the treatment of patients with positive blood culture results. Infect Control Hosp Epidemiol. 2010;31:1043-1048
28. Harbarth S, Cosgrove S, Carmeli Y. Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci. Antimicrob Agents Chemother. 2002;46:1619-1628
29. Flokas ME, Karageorgos SA, Detsis M. Vancomycin-resistant enterococci colonisation, risk factors and risk for infection among hospitalised paediatric patients: a systematic review and meta-analysis. Int J Antimicrob Agents. 2017;49:565-572
30. Monteserin N, Larson E. Temporal trends and risk factors for healthcare-associated vancomycin-resistant enterococci in adults. J Hosp Infect. 2016;94:236-241
31. Hammond DA, Smith MN, Li C. Systematic review and meta-analysis of acute kidney injury associated with concomitant vancomycin and piperacillin/tazobactam. Clin Infect Dis. 2017;64:666-674
32. Navalkele B, Pogue JM, Karino S. Risk of acute kidney injury in patients on concomitant vancomycin and piperacillin-tazobactam compared to those on vancomycin and cefepime. Clin Infect Dis. 2017;64:116-123
33. Schweizer ML, Furuno JP, Harris AD. Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia. BMC Infect Dis. 2011;11:279
34. Lockwood AM, Perez KK, Musick WL. Integrating rapid diagnostics and antimicrobial stewardship in two community hospitals improved process measures and antibiotic adjustment time. Infect Control Hosp Epidemiol. 2016;37:425-432